Shop
Checkout
CONFERENCES
REPORTS
MEDIA
PROFESSIONAL
EDUCATIONAL

Clinical Development

Therapies for Solid Tumors
September 2012
Table of Contents | Tables and Figures


Alzheimer's Disease
July 2012
Table of Contents | Tables and Figures
The New Generation of Antibody Therapeutics
June 2012
Table of Contents | Tables and Figures


Fragment-Based Drug Discovery
April 2012
Table of Contents | Tables and Figures
Back-Up Compound Strategies
April 2012
Table of Contents | Tables and Figures | Executive Summary


Hematological Cancer Therapies: Pipelines, Markets, and Business Considerations
February 2012
Table of Contents | Tables and Figures


The PI3K/Akt/mTOR Pathway
November 2011
Table of Contents | Tables and Figures | Executive Summary


New Trends in Preventive and Therapeutic Vaccines
October 2011
Table of Contents | Tables and Figures | Executive Summary


Cytokine-Based Therapies and Inhibitors:R&D Pipelines, Markets, and Strategic Issues
September 2011
Table of Contents | Tables and Figures | Executive Summary


Kinase-Targeted Therapeutics
August 2011
Table of Contents | Tables and Figures | Executive Summary
Engineering Next-Generation Therapeutic Proteins
July 2011
Table of Contents | Tables and Figures


Multitargeted Therapies
June 2011
Table of Contents | Tables and Figures


Commercializing Biomarkers in Therapeutic and Diagnostic Applications
May 2011
Table of Contents | Tables and Figures | Executive Summary


Molecular Diagnostics
February 2011
Table of Contents | Tables and Figures | Executive Summary


Advanced Drug Delivery Technologies
January 2011
Table of Contents | Tables and Figures | Executive Summary


The Antiviral Pipeline: HIV, HCV, and Influenza
November 2010
Table of Contents | Tables and Figures


Diabetes Pipeline: Intense Activity to Meet Unmet Need
September 2010
Table of Contents | Tables and Figures


Combination Drug/Diagnostics: Fueling Growth of Personalized Medicine
April 2010
Table of Contents | Tables and Figures | Executive Summary


Kinase Therapeutics: Pipeline Assessment and Commercial Prospects
January 2010
Table of Contents | Tables and Figures | Executive Summary


Multiplex Assays: Evolving Technologies, Applications and Future Directions
January 2010
Table of Contents | Tables and Figures | Executive Summary


Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response
December 2009
Table of Contents | Tables and Figures | Executive Summary


Immunotherapies and Vaccines for Nontraditional Indications
October 2009
Table of Contents | Tables and Figures | Executive Summary


Ion Channel Modulator Pipelines
September 2009
Table of Contents | Tables and Figures | Executive Summary
Outsourcing Preclinical Studies to China
July 2009
Table of Contents | Tables and Figures | Executive Summary
Pharmacogenomics: Delivering on the Promise
June 2009
Table of Contents | Tables and Figures | Executive Summary
Approaches to Reducing Phase II Attrition
May 2009
Table of Contents | Tables and Figures | Executive Summary
Medicinal Chemistry for Drug Discovery: Significance of Recent Trends
March 2009
Table of Contents | Tables and Figures | Executive Summary
Biomedical Imaging: From Drug Target Discovery to Medical Diagnostics
December 2008
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Neurodegenerative Diseases: Next-Generation Drugs for Four Major Disorders
December 2008
Table of Contents | Tables and Figures | Executive Summary

Conducting Clinical Trials in Europe: An Insider's Analysis
December 2008
Table of Contents | Tables and Figures | Executive Summary

Stem Cells Come of Age
November 2008
Table of Contents | Tables and Figures | Executive Summary

Immunotherapies and Vaccines for Cancer and Infectious Diseases
October 2008
Table of Contents | Tables and Figures | Executive Summary


GPCRs: Dawn of a New Era?
October 2008
Table of Contents | Tables and Figures | Executive Summary


Kinase Therapeutics Insight Update 2 (August 2008 - September 2008)
October 2008
Obesity Drug Pipeline: Developing Therapies for a Complex Disease
September 2008
Table of Contents | Tables and Figures | Executive Summary

Kinase Therapeutics Insight Update 1 (April 2008 - July 2008)
August 2008
Strategic Management of Resources and Portfolios
August 2008
Table of Contents | Tables and Figures | Executive Summary

Cancer Biomarkers: Adoption Is Driving Growth
July 2008
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Blood-Brain Barrier: Bridging Options for Drug Discovery & Development
May 2008
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Cardiotoxicity: Issues, Technologies, and Solutions for the Future
May 2008
Table of Contents | Tables and Figures | Executive Summary

Inflammatory Directions: Strategies for Six Diseases with Unmet Needs
April 2008
Table of Contents | Tables and Figures | Executive Summary

MicroRNAs: Commercial Products on the Horizon
March 2008
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Epigenetics: Technologies, Applications, and the Commercial Landscape
February 2008
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Kinase Therapeutic Pipelines: An Assessment of Targets and Agents in Development
December 2007
Table of Contents | Tables and Figures | Executive Summary

Molecular Diagnostics: A Rapidly Shifting Commercial and Technology Landscape
November 2007
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Monoclonal Antibodies: Pipeline Analysis and Market Assessment
October 2007
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Adaptive Clinical Trials: Innovation in Trial Design, Management, and Analysis
September 2007
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Backup Compound Strategies: Best Practices for Reducing Phase II Risk
September 2007
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Clinical Forecasting: A Novel Bayesian Tool for Predicting Phase III Outcomes
July 2007
Table of Contents | Tables and Figures | Executive Summary
Disease-Related Biomarkers: Their Potential in Patient Screening, Prognosis, and Stratification
June 2007
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Combination Drug/Diagnostic Products: Pathways to R&D and Commercial Success
May 2007
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Microdosing in Translational Medicine: Pros and Cons
May 2006
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

The Impact of Genomics on Clinical Trials and Medical Practice
April 2006
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Oncogenomics: The Future of Cancer Cure
January 2006
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

A New Paradigm for Clinical Development: The Clinical Trial in 2015
November 2005
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Combination Therapies: Benefits and Challenges in Drug, Device, and Biologicals Development
August 2005
Table of Contents | Tables and Figures | Executive Summary

Biomarkers in Clinical Development: Implications for Personalized Medicine and Streamlining R&D
March 2005
Table of Contents | Tables and Figures | Survey Questions | Executive Summary